132 related articles for article (PubMed ID: 7344610)
1. Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells.
Ludwig H; Fritz E
Anticancer Res; 1981; 1(6):329-34. PubMed ID: 7344610
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
Salmon SE; Hamburger AW; Soehnlen B; Durie BG; Alberts DS; Moon TE
N Engl J Med; 1978 Jun; 298(24):1321-7. PubMed ID: 77475
[TBL] [Abstract][Full Text] [Related]
3. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures.
Stewart AK; Prince HM; Cappe D; Chu P; Lutzko C; Sutherland DR; Dubé ID
Cancer Gene Ther; 1997; 4(3):148-56. PubMed ID: 9171933
[TBL] [Abstract][Full Text] [Related]
4. [New aspects in the clinical course determination and therapy in multiple myeloma].
Ludwig H; Pietschmann H
Acta Med Austriaca; 1979; 6(5):255-60. PubMed ID: 555224
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy].
Golenkov AK; Trifonova EV; Kataeva EV; Kil'diushevskiĭ AV; Lutskaia TD; Zariad'eva EA; Nazarova IN; Lukashina MN; Zabotina TN; Mikhaĭlova IN; Inshakov AN; Logacheva NP; Baryshnikov AIu
Ter Arkh; 2000; 72(8):38-41. PubMed ID: 11019426
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
[TBL] [Abstract][Full Text] [Related]
8. A new basis for treatment of multiple myeloma.
Salmon SE; Durie BG; Hamburger AW
Schweiz Med Wochenschr; 1978 Oct; 108(41):1568-72. PubMed ID: 694483
[TBL] [Abstract][Full Text] [Related]
9. [Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma].
Ohler L; Scholten C; Reiter E; Tiefengraber E; Jäger U; Strobl H; Lechner K; Höcker P; Geissler K
Wien Klin Wochenschr; 1993; 105(20):580-4. PubMed ID: 7505076
[TBL] [Abstract][Full Text] [Related]
10. The sensitivity testing of Wilms' tumors to cytostatic agents with an autoradiographic in vitro short-term test.
Willnow U
Neoplasma; 1984; 31(6):719-26. PubMed ID: 6097829
[TBL] [Abstract][Full Text] [Related]
11. [Human tumor stem cell assay].
Inoue K; Arakawa M; Ogawa M
Gan To Kagaku Ryoho; 1982 Apr; 9(4):599-605. PubMed ID: 7184417
[TBL] [Abstract][Full Text] [Related]
12. Human tumor colony assay and chemosensitivity testing.
Salmon SE
Cancer Treat Rep; 1984 Jan; 68(1):117-25. PubMed ID: 6692423
[TBL] [Abstract][Full Text] [Related]
13. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
[TBL] [Abstract][Full Text] [Related]
14. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
15. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
Tarella C; Boccadoro M; Omedé P; Bondesan P; Caracciolo D; Frieri R; Bregni M; Siena S; Gianni AM; Pileri A
Bone Marrow Transplant; 1993 Apr; 11(4):271-7. PubMed ID: 7683551
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
Montero JC; López-Pérez R; San Miguel JF; Pandiella A
Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
18. [Role of thalidomide in the treatment of multiple myeloma].
Mikala G; Jákó J; Vályi-Nagy I
Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Kraj M; Pogłód R; Maj S; Pawlikowski J; Sokołowska U; Szczepanik J
Acta Pol Pharm; 2002; 59(6):478-82. PubMed ID: 12669777
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD20 monoclonal antibody therapy in multiple myeloma.
Kapoor P; Greipp PT; Morice WG; Rajkumar SV; Witzig TE; Greipp PR
Br J Haematol; 2008 Apr; 141(2):135-48. PubMed ID: 18318769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]